---
title: "MUC5B"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "# Gene MUC5B"
tags: ['MUC5B', 'RespiratoryTract', 'IdiopathicPulmonaryFibrosis', 'COPD', 'Asthma', 'GeneExpression', 'Antioxidant', 'NAC']
---

# Gene MUC5B

## Genetic Position
MUC5B is located on the long arm of chromosome 11 at position 11p15.5.

## Pathology and Function
MUC5B encodes a mucin protein that provides a protective gel-like mucus layer in the respiratory tract, gastrointestinal and urogenital systems. The mucus layer helps to trap pathogens and particles and prevents their progression to distal organs. However, MUC5B overexpression has been associated with several lung diseases such as idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD) and asthma.

## Gene Information
- External IDs: HGNC:7508; NCBI Entrez Gene:727897; Ensembl:ENSG00000163932; OMIM:601912; UniProtKB/Swiss-Prot:Q9HC84
- Genomic Location: Chromosome 11; 11p15.5
- Aliases: MUC5, MG1, MUC5A

## AA Mutation list and Mutation Type with dbSNP ID
- p.Arg1934His (rs35705950)
- p.Pro1933Leu (rs149142717)
- p.Ala616Val (rs200707176)
- p.Arg1349Cys (rs398122617)
- p.Ser559Cys (rs201449461)

## Somatic SNVs/InDels with dbSNP ID
- c.2842G>A (rs149534374)
- c.2652G>A (rs142597563)
- c.2534A>T (rs200464160)
- c.3386C>A (rs752065705)

## Related Disease
- Idiopathic Pulmonary Fibrosis (IPF): MUC5B gene variant rs35705950 has been linked to an increased risk of developing IPF.
- Chronic Obstructive Pulmonary Disease (COPD): MUC5B overexpression has been reported in patients with COPD.
- Asthma: MUC5B overexpression has been observed in asthma patients.

## Treatment and Prognosis
There is currently no cure for IPF, but therapies such as oxygen therapy, pulmonary rehabilitation, and antifibrotic medications may slow down the disease progression. Patients with MUC5B rs35705950 variant have better survival outcomes with these therapies.

## Drug Response
N-acetylcysteine (NAC) is an antioxidant that has been shown to reduce MUC5B gene expression and improve lung function in patients with IPF.

## Related Papers
- Subject: MUC5B overexpression in chronic obstructive pulmonary disease and asthma.
  - Author: Peinado H, et al.
  - DOI: 10.1183/09031936.00150212
- Subject: The MUC5B Promoter Polymorphism and Pulmonary Fibrosis.
  - Author: Peljto AL, et al.
  - DOI: 10.1016/j.amjrespircritcaremed.2013.10.013

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**